Serum GFAP and NfL augment a metabolomics-driven strategy for long-term prediction of multiple sclerosis progression. - Kacerova T; Willemse E; Oechtering J; Radford-Smith DE; Xiong W; Sealey M; Saldana L; Maleska Maceski A; Yeo T; DeLuca G; Palace J; Leppert D; et al. (Communications medicine, 2026)